CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Imba Institut Fr Molekulare Biotechnologie's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 7, 2025
Patent NumberGrant DateTitleTotal Oppositions
Aug 21, 2024Heart Tissue Model1
May 2, 2018Breast Cancer Therapeutics2